Search Results - "Zammit, Gary K"

Sleep Duration as a Risk Factor for Diabetes Incidence in a Large US Sample by GANGWISCH, James E, HEYMSFIELD, Steven B, BODEN-ALBALA, Bernadette, BUIJS, Ruud M, KREIER, Felix, PICKERING, Thomas G, RUNDLE, Andrew G, ZAMMIT, Gary K, MALASPINA, Dolores

“…To explore the relationship between sleep duration and diabetes incidence over an 8- to 10-year follow-up period in data from the First National Health and…”
Get full text

Comparison of actigraphy and polysomnography to assess effects of zolpidem in a clinical research unit by Peterson, Barry T, Chiao, Ping, Pickering, Eve, Freeman, Jon, Zammit, Gary K, Ding, Yu, Badura, Lori L

“…Abstract Objective This study sought to compare devices that use actigraphy for measuring sleep endpoints in the clinical research unit (CRU) and home…”
Get full text

Earlier Parental Set Bedtimes as a Protective Factor Against Depression and Suicidal Ideation by GANGWISCH, James E, BABISS, Lindsay A, MALASPINA, Dolores, TURNER, J. Blake, ZAMMIT, Gary K, POSNER, Kelly

Get full text

Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia by Zammit, Gary K., McNabb, Louis J., Caron, Judy, Amato, David A., Roth, Thomas

“…SUMMARY Objective: Eszopiclone is a new, single-isomer, non-benzodiazepine, cyclopyrrolone agent under investigation for the treatment of insomnia. The present…”
Get full text

Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study by Cheng, Jocelyn Y., Filippov, Gleb, Moline, Margaret, Zammit, Gary K., Bsharat, Mohammad, Hall, Nancy

“…Lemborexant is a dual orexin receptor antagonist indicated for the treatment of adult and elderly individuals with insomnia. Some current pharmacologic…”
Get full text

The effect of vestibular stimulation in a four-hour sleep phase advance model of transient insomnia by Krystal, Andrew D, Zammit, Gary K, Wyatt, James K, Quan, Stuart F, Edinger, Jack D, White, David P, Chiacchierini, Richard P, Malhotra, Atul

“…To determine if vestibular stimulation is an effective therapy for transient insomnia in a sleep phase advance model. Multi-site, double-blind, randomized,…”
Get full text

Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment by Schweitzer, Paula K, Mayer, Geert, Rosenberg, Russell, Malhotra, Atul, Zammit, Gary K, Gotfried, Mark, Chandler, Patricia, Baladi, Michelle, Strohl, Kingman P

“…Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, is approved in the United States to improve wakefulness in adults with excessive daytime sleepiness…”
Get full text

Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial by Schweitzer, Paula K, Rosenberg, Russell, Zammit, Gary K, Gotfried, Mark, Chen, Dan, Carter, Lawrence P, Wang, Hao, Lu, Yuan, Black, Jed, Malhotra, Atul, Strohl, Kingman P

“…Primary treatment of obstructive sleep apnea can be accompanied by a persistence of excessive sleepiness despite adherence. Furthermore, effectiveness of sleep…”
Get full text

Earlier parental set bedtimes as a protective factor against depression and suicidal ideation by Gangwisch, James E, Babiss, Lindsay A, Malaspina, Dolores, Turner, J Blake, Zammit, Gary K, Posner, Kelly

“…To examine the relationships between parental set bedtimes, sleep duration, and depression as a quasi-experiment to explore the potentially bidirectional…”
Get full text

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study by Krystal, Andrew D, Erman, Milton, Zammit, Gary K, Soubrane, C, Roth, Thomas

“…To evaluate long-term efficacy and safety of zolpidem extended-release 3 to 7 nights/week for chronic primary insomnia. Multicenter, 25-week, phase IIIb,…”
Get full text

Alterations in sleep architecture in response to experimental sleep curtailment are associated with signs of positive energy balance by Shechter, Ari, O'Keeffe, Majella, Roberts, Amy L, Zammit, Gary K, RoyChoudhury, Arindam, St-Onge, Marie-Pierre

“…Sleep reduction is associated with increased energy intake and weight gain, though few studies have explored the relationship between sleep architecture and…”
Get more information

Short Sleep Duration as a Risk Factor for Hypertension: Analyses of the First National Health and Nutrition Examination Survey by Gangwisch, James E, Heymsfield, Steven B, Boden-Albala, Bernadette, Buijs, Ruud M, Kreier, Felix, Pickering, Thomas G, Rundle, Andrew G, Zammit, Gary K, Malaspina, Dolores

“…Depriving healthy subjects of sleep has been shown to acutely increase blood pressure and sympathetic nervous system activity. Prolonged short sleep durations…”
Get full text

A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults by Bullock, Amy, Gunduz‐Bruce, Handan, Zammit, Gary K., Qin, Min, Li, Haihong, Sankoh, Abdul J., Silber, Christopher, Kanes, Stephen J., Jonas, Jeffrey, Doherty, James

“…Objective To evaluate single zuranolone (SAGE‐217) 30 or 45 mg doses in a 5‐h phase advance insomnia model. Methods In this double‐blind, three‐way crossover…”
Get full text

Short Sleep Duration as a Risk Factor for Hypercholesterolemia: Analyses of the National Longitudinal Study of Adolescent Health by GANGWISCH, James E, MALASPINA, Dolores, BABISS, Lindsay A, OPLER, Mark G, POSNER, Kelly, SA SHEN, TURNER, J. Blake, ZAMMIT, Gary K, GINSBERG, Henry N

“…To explore the relationship between sleep duration in adolescence and hypercholesterolemia in young adulthood. Experimental sleep restriction has been shown to…”
Get full text

Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study by Cheng, Jocelyn Y., Moline, Margaret, Zammit, Gary K., Filippov, Gleb, Bsharat, Mohammad, Hall, Nancy

“…Background and Objective Lemborexant is a dual orexin receptor antagonist recently approved in the USA, Japan, and Canada for the treatment of adults with…”
Get full text

Sleep Duration Associated with Mortality in Elderly, but not Middle-Aged, Adults in a Large US Sample by GANGWISCH, James E, HEYMSFIELD, Steven B, BODEN-ALBALA, Bernadette, BUIJS, Ruud M, KREIER, Felix, OPLER, Mark G, PICKERING, Thomas G, RUNDLE, Andrew G, ZAMMIT, Gary K, MALASPINA, Dolores

“…To explore age differences in the relationship between sleep duration and mortality by conducting analyses stratified by age. Both short and long sleep…”
Get full text

Insomnia and Sleep Duration as Mediators of the Relationship Between Depression and Hypertension Incidence by Gangwisch, James E., Malaspina, Dolores, Posner, Kelly, Babiss, Lindsay A., Heymsfield, Steven B., Turner, J. Blake, Zammit, Gary K., Pickering, Thomas G.

“…Background Depression has been found to predict the incidence of hypertension and other adverse cardiovascular events in prospective studies. Insomnia and…”
Get full text

Reliability and Validity of the Brief Insomnia Questionnaire in the America Insomnia Survey by KESSLER, Ronald C, COULOUVRAT, Catherine, ZAMMIT, Gary K, HAJAK, Goeran, LAKOMA, Matthew D, ROTH, Thomas, SAMPSON, Nancy, SHAHLY, Victoria, SHILLINGTON, Alicia, STEPHENSON, Judith J, WALSH, James K

“…to evaluate the reliability and validity of the Brief Insomnia Questionnaire (BIQ), a fully structured questionnaire developed to diagnose insomnia according…”
Get full text

Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications by Greenblatt, David J, Zammit, Gary K

“…Eszopiclone is the active S-enantiomer of R,S-zopiclone, and is a cyclopyrrolone hypnotic acting via the GABA-benzodiazepine receptor system. Nearly 6 million…”
Get more information

Insufficient evidence for the use of automated and semi-automated scoring of polysomnographic recordings by Zammit, Gary K

Get full text